APA

Fukuoka M., Niitani H., Suzuki A., Motomiya M., Hasegawa K., Nishiwaki Y., Kuriyama T., Ariyoshi Y., Negoro S. & Masuda N. (19920127). A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyama T, Ariyoshi Y, Negoro S and Masuda N. 19920127. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Fukuoka M., Niitani H., Suzuki A., Motomiya M., Hasegawa K., Nishiwaki Y., Kuriyama T., Ariyoshi Y., Negoro S. and Masuda N. (19920127). A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyama T, Ariyoshi Y, Negoro S and Masuda N. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19920127.